Who Paid My Doc
Clifton Clarke
Critical Care Medicine Chicago, IL Medical Doctor
NPI 1205849015 CMS profile 796091
500 E 51St St, Chicago, IL 60615
General payments
$3,237
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Clifton Clarke of Chicago, IL is reported in the CMS Open Payments database as having received $3,237 across 3 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 80th percentile of Critical Care Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
2 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $3,188 | 1 | |
| 2023 | General | $49 | 2 |
Beside peers
- Clifton Clarke
- Critical Care Medicine median
- Middle half of Critical Care Medicine
- National median
In program year 2025, general payments to Clifton Clarke were reported at $3,188. Among 2,664 Critical Care Medicine profiles paid that year, the median was $189 and the middle half received between $59 and $844.
Show as a table
| Year | Clifton Clarke | Critical Care Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $149 | $51–$535 | $163 |
| 2020 | $0 | $110 | $30–$325 | $114 |
| 2021 | $0 | $125 | $34–$403 | $132 |
| 2022 | $0 | $157 | $49–$582 | $149 |
| 2023 | $49 | $162 | $56–$621 | $160 |
| 2024 | $0 | $168 | $53–$634 | $164 |
| 2025 | $3,188 | $189 | $59–$844 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 7 drugsPart D claims
147
Drug cost
$42,912
Branded share of claims
75.5%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Spiriva Handihaler Tiotropium Bromide | Brand | 16 | $14,355 | |
| Breo Ellipta Fluticasone/Vilanterol | Brand | 21 | $11,180 | |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | Brand | 15 | $10,868 | |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | Brand | 17 | $2,987 | |
| Wixela Inhub Fluticasone Propion/Salmeterol | Brand | 14 | $2,063 | |
| Albuterol Sulfate Hfa Albuterol Sulfate | Brand | 28 | $1,406 | |
| Prednisone | Generic | 36 | $53 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 104,182 Part D prescribers listed as Internal Medicine; they describe a distribution and say nothing about conduct.
Records
3 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Critical Care Medicine in Illinois
Brian Reichardt
Critical Care Medicine · O Fallon, IL
Michael Cuttica
Critical Care Medicine · Chicago, IL
Daniel Dilling
Critical Care Medicine · Maywood, IL
Israel Rubinstein
Critical Care Medicine · Chicago, IL
John Rickelman
Critical Care Medicine · Quincy, IL
Husam Nayef
Critical Care Medicine · Palos Park, IL
Related records
Critical Care Medicine in Illinois
Practitioners in the same specialty and state, ranked by reported value.
All Critical Care Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Illinois
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.